— Know what they know.
Not Investment Advice

SKTO OTC

SK3 Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -98.0% 5Y: -90.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $3020 mcap · 302M float · 0.016% daily turnover

Income Trends

Revenue
$53M +0.0% ▲
4Y CAGR: +543.4%
Gross Profit
$53M +0.0% ▲
4Y CAGR: +1056.0%
Operating Income
$27M +0.0% ▲
4Y CAGR: +424.1%
Net Income
$17M +0.0% ▲
EPS (Diluted)
$2.43 +0.0% ▲
EBITDA
$26M +0.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2004FY2005FY2006FY2007FY2013
Revenue$31K$31K$936$0$53M
YoY Growth+0.0%-0.5%-96.9%-100.0%+0.0%
Cost of Revenue$28K$17K$3K$0$33K
Gross Profit$3K$13K-$2K$0$53M
Gross Margin9.6%43.9%-228.4%—99.9%
R&D Expenses$0$0$0$0$0
SG&A Expenses$34K$90K$36K$90K$26M
Operating Expenses-$32K-$63K-$39K-$90K$26M
Operating Income$35K$77K$36K$90K$27M
Operating Margin114.1%250.5%3898.9%—50.2%
Interest Expense$0$0$0$0$59K
Income Before Tax$0$0$0$0$26M
Tax Expense$0$0$0$0$9M
Net Income-$53K-$77K-$66K-$90K$17M
Net Margin-171.8%-250.5%-7081.9%—32.1%
EPS (Diluted)$-0.01$-0.01$-0.01$-0.01$2.43
EBITDA-$35K-$76K-$36K-$90K$26M
Shares Outstanding10M10M11M22M7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms